MedTrace Logo

Systemic Treatment of Moderate-to-severe Psoriasis in Adults: Update of the French Guidelines

NCT05144165 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2021-12-03

No results posted yet for this study

Summary

French guidelines on the use of systemic treatments for moderate-to-severe psoriasis in adults have been developed by the psoriasis research group of the French Society of Dermatology using literature available until July 2017 (Amatore et al, 2019). Because several systemic treatments have been marketed since then, new guidelines are mandatory. The aim of this study coordinated by the Centre of Evidence of the French Society of Dermatology is to update the available French guidelines using a Delphi method.

Conditions

  • Psoriasis
  • Psoriasis Palmaris
  • Psoriasis Inverse
  • Psoriasis Vulgaris
  • Psoriatic Nail
  • Psoriatic Plaque
  • Psoriasis Guttate
  • Psoriasis of Scalp
  • Psoriasis Universalis
  • Psoriatic Erythroderma
  • Psoriasis Pustular

Interventions

OTHER

Experts consensus

Consensus opinion using Delphi Methodology

Sponsors & Collaborators

  • Centre of Evidence of the French Society of Dermatology

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-08
Primary Completion
2022-03-31
Completion
2022-03-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05144165 on ClinicalTrials.gov